Inaktiver Wert

Andere Sprachen ehave Inc Other OTC

Aktien

CA28238M1068

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

EHAVE : Changes in Registrant’s Certifying Accountant - Form 6-K	24.05.23
EHAVE : Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review - Form 6-K	02.05.23
Ei.Ventures, Inc. cancelled the acquisition of Mycotopia Therapies Inc. from EHAVE, Inc. (OTCPK:EHVV.F) and others in a reverse merger transaction.	16.02.23
Ehave Provides Progress Update on its HPPD Study with University of Melbourne	02.02.23
FDA Grants Ehave Consent to Proceed With Its Clinical Study on Intravenous Ketamine Infusion for Major Depressive Disorder	15.12.22
FDA Grants EHAVE, Inc. Consent to Proceed with Its Clinical Study on Intravenous Ketamine Infusion for Major Depressive Disorder	15.12.22
Ehave Shareholder from CEO Ben Kaplan and Corporate Update	07.12.22
Ehave, Inc. Announces its KetaDASH Mobile Unit will be Delivered to Miami Beach on June 10, 2022	03.06.22
Ehave, Inc. Announces Psychedelics Precision Medicine Platform For Clinical Research	01.06.22
EHAVE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	27.05.22
EHAVE, Inc. Auditor Raises 'Going Concern' Doubt	27.05.22
EHAVE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	23.05.22
Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ	23.05.22
Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ	23.05.22
Ehave Inc. (Stock Symbol: EHVVF) Announces MetaHealthU Will Enter The Market With A Focus On HPPD	20.04.22
Ehave Announces MetaHealthU Will Enter The Market With A Focus On HPPD	19.04.22
Ehave, Inc. Announces MetaHealthU Will Enter The Market With A Focus On HPPD	19.04.22
Ehave Continues Expansion Of KetaDASH Mobile Psychedelic Service By Providing Licensed Psychotherapists And Registered Nurses	03.03.22
Ehave, Inc. Continues Expansion Of KetaDASH Mobile Psychedelic Service By Providing Licensed Psychotherapists And Registered Nurses	03.03.22
Ehave, Inc. Licensing Partner Vastmindz Seen By Millions Of Viewers On Unicorn Hunter	24.02.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen ehave Inc Other OTC

Aktien

CA28238M1068

Andere Sprachen

Filter